Please Wait...

Fetuin-A

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Fetuin A, also known as α-2-HS glycoprotein (AHSG) is a well conserved glycoprotein implicated in the regulation of phosphorus and calcium homeostasis. Fetuin-A has also a role in inflammation and metabolic disease as it binds to minerals, lipids, lectins, proteases and has TGF-β antagonist and insulin receptor antagonist action. Fetuin A is synthetized by the liver and circulates in blood at high concentrations. For example, fetal calf serum contains less albumin than fetuin-A (Jahnen-Dechent et al., 2011). Fetuin-A is also present in calciprotein particles (cytotoxic particles containing inorganic calcium-phosphate crystals and mineral binding proteins) in patient with chronic kidney diseases (Kuro-o, 2013).

Bioclinica Lab employs a manual sandwich immunoassay designed for the measurement of Fetuin A in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join Bioclinica in a live #Xtalks webinar 10/31 exploring challenges & benefits of different sourcing models to man… https://t.co/kRYNc1Z3gj
bioclinica (2 hours ago)
Bioclinica contributions toward advancement of #Alzheimer's disease research & therapies showcased in 8 different s… https://t.co/j96UN9568o
bioclinica (8 hours ago)
Bioclinica’s Joby John reflects on the #SCDM2018 Annual Conference & being a part a thriving community of clinical… https://t.co/c70gH5kJo9
bioclinica (Yesterday)
RT @bioclinica: Our own Jeff Heilbraun is in Tokyo nxt wk to lead a discussion at DIA’s Cardiac Safety Workshop in Japan. Jeff will give an…
bioclinica (Yesterday)
RT @Xtalks: Trends in #SitePayments: Insight into How CROs Can Gain a Competitive Edge This webinar will focus on the latest market researc…
bioclinica (Yesterday)
Great connecting w @bioclinica clients Odonate Therapeutics, Eisai, & PCI Biotech, at #ESMO18 #oncology… https://t.co/4wKrLof8e6
bioclinica (Yesterday)

Latest Blogs:

Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner